Resolution of Decompensated Cirrhosis From Wilson’s Disease With Zinc Monotherapy: A Potential Therapeutic Option?
Authors:
- Patrick G. NorthupPNPatrick G. Northup
- Carl L. BergCBCarl L. Berg
- 1 August 2006
- journal article
- case report
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 4 (8) , 1069-1071
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Diagnosis and current therapy of Wilson's diseaseAlimentary Pharmacology & Therapeutics, 2004
- Treatment of Wilson's disease with zinc. XVIII. Initial treatment of the hepatic decompensation presentation with trientine and zincJournal of Laboratory and Clinical Medicine, 2003
- A Practice Guideline on Wilson DiseaseHepatology, 2003
- Treatment of Wilson's disease with zinc: XV long-term follow-up studiesJournal of Laboratory and Clinical Medicine, 1998
- Effects of long-term treatment in Wilson's disease withd-penicillamine and zinc sulphateJournal of Neurology, 1996
- Oral zinc as initial therapy in Wilson's disease: two years of continuous treatment in a 10‐year‐old childActa Paediatrica, 1992
- Oral zinc sulphate as primary therapeutic intervention in a child with Wilson diseaseEuropean Journal of Pediatrics, 1989
- Worsening of Neurologic Syndrome in Patients With Wilson's Disease With Initial Penicillamine TherapyArchives of Neurology, 1987
- Management of Wilson's disease with zinc sulphateJournal of the Neurological Sciences, 1987
- Effective treatment of Wilson's disease with oral zinc sulphate: two case reports.BMJ, 1984